Vertraagde tijd
Japan Exchange
07:20:10 01-05-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
650
JPY
|
-0,61%
|
|
-1,81%
|
+1,56%
|
Fiscaal tijdperk: Juni |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Marktkapitalisatie
1 |
10.813
|
5.391
|
7.405
|
5.104
|
4.307
|
4.424
|
Bedrijfswaarde
1 |
9.392
|
4.371
|
6.204
|
4.011
|
3.035
|
2.994
|
K/w-verhouding
|
-68,9
x
|
-11,5
x
|
-157
x
|
87,9
x
|
16,1
x
|
15,5
x
|
Dividendrendement
|
-
|
-
|
-
|
-
|
-
|
1,34%
|
Marktkapitalisatie/omzet
|
11,5
x
|
6,43
x
|
6,62
x
|
4,54
x
|
3,52
x
|
3,41
x
|
Bedrijfswaarde/omzet
|
10
x
|
5,21
x
|
5,55
x
|
3,57
x
|
2,48
x
|
2,31
x
|
Bedrijfswaarde/EBITDA
|
-117
x
|
-13,2
x
|
207
x
|
42,2
x
|
11,9
x
|
10,3
x
|
Bedrijfswaarde/FCF
|
-40,3
x
|
-16,9
x
|
38,7
x
|
-67,3
x
|
20,4
x
|
36,2
x
|
FCF Yield
|
-2,48%
|
-5,93%
|
2,58%
|
-1,49%
|
4,91%
|
2,76%
|
Price to Book
|
6,16
x
|
4,44
x
|
6,11
x
|
4,05
x
|
2,9
x
|
2,5
x
|
Aantal aandelen (in duizenden)
|
5.848
|
5.854
|
5.887
|
5.900
|
5.900
|
5.907
|
Referentieprijs
2 |
1.849
|
921,0
|
1.258
|
865,0
|
730,0
|
749,0
|
Datum van publicatie
|
26/06/18
|
25/09/19
|
29/09/20
|
27/09/21
|
26/09/22
|
25/09/23
|
Fiscaal tijdperk: Juni |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Omzet
1 |
938
|
839
|
1.118
|
1.124
|
1.223
|
1.299
|
EBITDA
1 |
-80
|
-332
|
30
|
95
|
255
|
291
|
Bedrijfsresultaat (EBIT)
1 |
-141
|
-396
|
-17
|
40
|
191
|
211
|
Operationele Marge
|
-15,03%
|
-47,2%
|
-1,52%
|
3,56%
|
15,62%
|
16,24%
|
Resultaat voor belastingen (EBT)
1 |
-149
|
-465
|
-24
|
51
|
262
|
237
|
Nettowinst (verlies)
1 |
-156
|
-469
|
-47
|
58
|
267
|
285
|
Nettomarge
|
-16,63%
|
-55,9%
|
-4,2%
|
5,16%
|
21,83%
|
21,94%
|
WPA
2 |
-26,83
|
-80,16
|
-8,018
|
9,837
|
45,25
|
48,26
|
Free Cash Flow
1 |
-233,1
|
-259,1
|
160,4
|
-59,62
|
149,1
|
82,62
|
FCF-marge
|
-24,85%
|
-30,88%
|
14,34%
|
-5,3%
|
12,19%
|
6,36%
|
Kasstroomconversie (ebitda)
|
-
|
-
|
534,58%
|
-
|
58,48%
|
28,39%
|
Kasstroomconversie (nettowinst)
|
-
|
-
|
-
|
-
|
55,85%
|
28,99%
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
10,00
|
Datum van publicatie
|
26/06/18
|
25/09/19
|
29/09/20
|
27/09/21
|
26/09/22
|
25/09/23
|
Fiscaal tijdperk: Juni |
2020 S1
|
2021 S1
|
2022 Q1
|
2022 S1
|
2022 Q3
|
2023 Q1
|
2023 S1
|
2023 Q3
|
2024 Q1
|
2024 S1
|
---|
Omzet
1 |
454
|
537
|
173
|
533
|
477
|
262
|
610
|
465
|
235
|
632
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Bedrijfsresultaat (EBIT)
1 |
-123
|
2
|
-44
|
76
|
192
|
1
|
84
|
178
|
-30
|
71
|
Operationele Marge
|
-27,09%
|
0,37%
|
-25,43%
|
14,26%
|
40,25%
|
0,38%
|
13,77%
|
38,28%
|
-12,77%
|
11,23%
|
Resultaat voor belastingen (EBT)
1 |
-116
|
1
|
-37
|
88
|
223
|
6
|
90
|
179
|
-12
|
89
|
Nettowinst (verlies)
1 |
-118
|
-7
|
-48
|
82
|
199
|
-17
|
74
|
154
|
-38
|
71
|
Nettomarge
|
-25,99%
|
-1,3%
|
-27,75%
|
15,38%
|
41,72%
|
-6,49%
|
12,13%
|
33,12%
|
-16,17%
|
11,23%
|
WPA
2 |
-20,26
|
-1,240
|
-8,280
|
13,92
|
33,72
|
-2,980
|
12,56
|
26,15
|
-6,470
|
12,02
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
7/02/20
|
12/02/21
|
12/11/21
|
14/02/22
|
13/05/22
|
11/11/22
|
14/02/23
|
12/05/23
|
10/11/23
|
14/02/24
|
Fiscaal tijdperk: Juni |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Nettoschuldpositie
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Nettokaspositie
1 |
1.421
|
1.020
|
1.201
|
1.093
|
1.272
|
1.430
|
Hefboom (schuld/ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-233
|
-259
|
160
|
-59,6
|
149
|
82,6
|
ROE (netto-inkomsten/eigen vermogen)
|
-8,64%
|
-22,5%
|
-3,87%
|
4,69%
|
19,5%
|
17,5%
|
ROA (netto-inkomsten/totale activa)
|
-4,47%
|
-12,9%
|
-0,73%
|
1,58%
|
6,47%
|
6,05%
|
Totale activa
1 |
3.490
|
3.640
|
6.426
|
3.667
|
4.128
|
4.710
|
Nettoactief per aandeel
2 |
300,0
|
207,0
|
206,0
|
213,0
|
252,0
|
300,0
|
Cashflow per aandeel
2 |
216,0
|
162,0
|
190,0
|
211,0
|
255,0
|
280,0
|
Capex
1 |
85
|
114
|
34
|
26
|
142
|
98
|
Capex/omzet
|
9,06%
|
13,54%
|
3,04%
|
2,31%
|
11,61%
|
7,54%
|
Datum van publicatie
|
26/06/18
|
25/09/19
|
29/09/20
|
27/09/21
|
26/09/22
|
25/09/23
|
|
Vaira. 1 jan.
|
Kapi.
|
---|
| +1,56% | 24,57 mln. | | +0,17% | 42,19 mld. | | +10,92% | 42,24 mld. | | +44,30% | 40,15 mld. | | -6,20% | 28,31 mld. | | +5,23% | 24,63 mld. | | -24,79% | 18,2 mld. | | +26,69% | 12,01 mld. | | -3,13% | 11,76 mld. | | +6,57% | 10,4 mld. |
Biotechnologie & Medisch Onderzoek - Andere
|